HLN 10.13 Haleon plc
| Range: | 7.695-10.8 | Vol Avg: | 4817932 | Last Div: | 0.16 | Changes: | -0.07 |
| Beta: | 0.19 | Cap: | 45.80B | Currency: | USD | Exchange: | NYSE |
| Sector: | Healthcare | IPO: | Mon Jul 25 2022 | Empoloyees: | 25408 | ||
| CUSIP: | 405552100 | CIK: | 0001900304 | ISIN: | US4055521003 | Country: | GB |
| CEO: | Mr. Brian James McNamara | Website: | https://www.haleon.com | ||||
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Stock Details
Positive 0.44
Haleon gets target hike as UBS raises 'forever' sales target
Haleon PLC (LSE:HLN, NYSE:HLN) has received a price target upgrade from UBS ahead of its t...
proactiveinvestors.co.uk·Wed Oct 09 2024
Neutral 0.00
Futura Medical in line for $5m milestone payment as Haleon's US Eroxon launch gets underway
Futura Medical PLC (AIM:FUM, OTC:FAMDF) has secured a $5 million milestone payment followi...
proactiveinvestors.co.uk·Mon Oct 07 2024
Positive 0.53
HLN or PODD: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already he...
zacks.com·Thu Oct 03 2024
Positive 0.27
Haleon's buy rating restated after Pfizer cuts down stake
UBS has reiterated its buy rating on Haleon PLC (LSE:HLN, NYSE:HLN) shares after news that...
proactiveinvestors.co.uk·Tue Oct 01 2024
Positive 0.30
Haleon buys back some shares as Pfizer sells down stake
Haleon PLC (LSE:HLN, NYSE:HLN) said it has agreed to buy £230 million of its own shares fr...
proactiveinvestors.co.uk·Tue Oct 01 2024
Positive 0.60
Sensodyne maker Haleon to raise stake in China JV
British consumer healthcare company Haleon said on Friday it has agreed to raise its stake...
reuters.com·Fri Sep 27 2024
Positive 0.22
Haleon lays out pricing for £1bn bond offering
Haleon PLC (LSE:HLN, NYSE:HLN) has unveiled pricing for a near-£1 billion bond offering se...
proactiveinvestors.co.uk·Thu Sep 12 2024
Новини маркету
Найкращі для покупки
Контент, наданий на цьому сайті, призначений лише для інформаційних цілей і не є фінансовою, інвестиційною чи професійною порадою. Ми не є зареєстрованими інвестиційними радниками або фінансовими планерами, і ми не надаємо рекомендацій чи порад щодо купівлі, продажу або утримання будь-яких конкретних акцій або цінних паперів. Будь-які інвестиційні рішення слід приймати на основі власних досліджень та консультацій з кваліфікованим фінансовим фахівцем. Ми не несемо відповідальності за будь-які фінансові втрати чи збитки, понесені внаслідок покладання на інформацію, надану на цьому сайті. Будь ласка, інвестуйте відповідально та звертайтесь за професійною порадою, коли це потрібно.
• Створено StackThrow